VRPX
Virpax Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Next report
Analyst consensus
- Next report date
- Nov 19, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Mar 3, 2025
- EPS actual
- -$0.80
- EPS estimate
- -$0.27
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -12773.6%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 19, 2026